EIZO Corporation (TSE: 6737), the Hakusan, Ishikawa-based specialist in medical, industrial, business, and creative-work display monitors, reported FY3/2026 consolidated J-GAAP results in which the headline lines told two very different stories. Revenue inched up 1.0% to ¥81.3 billion, but operating profit fell 36.2% to ¥2.4 billion, and ordinary profit slipped 17.2% to ¥3.8 billion — operating metrics that would normally signal a difficult year. However, profit attributable to owners of the parent surged 76.5% to ¥7.3 billion, driven by sizeable non-operating gains. Basic EPS reached ¥180.64 (vs ¥100.81), and comprehensive income swung sharply to ¥20.6 billion from a ¥0.9 billion deficit.
The OP decline: mix and cost
EIZO's core operating-profit weakness reflects the natural lag in the company's medical and industrial monitor businesses, where the product mix shifted toward newer launches that carry higher initial component costs and where SG&A investment in next-generation development (medical 4K/8K imaging, factory-automation displays, defense imaging) continued. The company's flagship RadiForce medical line and DuraVision industrial line both expanded their portfolios with the May 2025 commissioning of EIZO's second Hakusan factory, a $25 million facility dedicated to medical and industrial monitor manufacturing. The ramp-up costs of that plant continue to weigh on margins through the early FY3/2026 quarters, with management positioning the facility as a multi-year growth driver.
Bottom-line surprise from investment securities
The net-line strength came primarily from non-operating items: gains on the sale of investment securities and the upward revaluation of strategic equity holdings (Japan's continued shift to mark-to-market accounting for cross-shareholdings under the FSA's policy stack drove a one-time positive). The standalone (non-consolidated) figures help isolate the underlying picture: parent-only operating profit was ¥0.7 billion (-45.7%), ordinary profit was ¥2.4 billion (-6.1%), and net profit was ¥5.9 billion (+62.2%) — confirming that the consolidated-net jump is securities-related rather than operating-business momentum.
Balance sheet remains exceptionally strong
EIZO's balance sheet continued to reflect one of the most conservative capital structures in the Japanese listed display industry. Total assets grew to ¥177.5 billion from ¥157.8 billion, net assets rose to ¥136.9 billion from ¥124.4 billion, and the equity ratio remained at 77.2% (vs 78.8% prior). Net assets per share reached ¥3,463.64. Operating cash flow was ¥5.6 billion (down from ¥11.5 billion as inventory and receivable working-capital effects unwound), and the company finished the year with cash and equivalents of ¥20.4 billion. The 2024 1-for-2 stock split is fully reflected in the per-share metrics.
Dividend up to ¥110, FY27 OP guidance lifts 39%
The annual dividend was raised to ¥110.00 per share (¥55.00 interim + ¥55.00 year-end), with the FY3/2027 forecast advanced to ¥115.00 (¥57.50 + ¥57.50). The FY3/2027 consolidated guidance signals an operating-profit recovery: revenue of ¥85.0 billion (+4.5%), operating profit of ¥3.3 billion (+39.5%), ordinary profit of ¥4.6 billion (+21.9%), and profit attributable to owners of the parent of ¥6.5 billion (-11.2%) — the net-line decline reflects the non-recurrence of FY26's investment-securities tailwind, while the operating rebound is driven by the new Hakusan factory moving from ramp-up to higher utilization, plus continued product-mix shift toward higher-margin healthcare and industrial monitors. Basic EPS guidance is ¥167.60.
| Metric | FY3/2026 | FY3/2025 | YoY |
|---|---|---|---|
| Revenue (¥ billion) | 81.3 | 80.5 | +1.0% |
| Operating profit (¥ billion) | 2.4 | 3.7 | −36.2% |
| Ordinary profit (¥ billion) | 3.8 | 4.6 | −17.2% |
| Profit attrib. to owners (¥ billion) | 7.3 | 4.1 | +76.5% |
| Basic EPS (¥) | 180.64 | 100.81 | +79.2% |
| Equity ratio | 77.2% | 78.8% | −1.6pp |
| Comprehensive income (¥ billion) | 20.6 | −0.9 | — |
| Annual dividend (¥) | 110.00 | 105.00 | +4.8% |
JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.